Trial Profile
Effect of temozolomide in patients with Relapse/Refractory primary Intra-Ocular Lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 May 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Eye neoplasms; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 05 May 2015 New trial record